First Eagle Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

First Eagle Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-500,000	Closed	-$900K	–	152
2019 Q2	$900K	Hold	500,000	–	–	﹤0.01%	139
2019 Q1	$940K	Hold	500,000	–	–	﹤0.01%	144
2018 Q4	$590K	Hold	500,000	–	–	﹤0.01%	153
2018 Q3	$1.35M	Hold	500,000	–	–	﹤0.01%	156
2018 Q2	$955K	Buy	+500,000	New	+$1.01M	﹤0.01%	158

Other funds holding INFI

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

First Eagle Investment Management's INFI Position: Q3 2019 in Review

First Eagle Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2019, closing a stake of 500,000 shares — an estimated $900K sold.

First Eagle Investment Management first reported a position in INFI in Q2 2018 and held it in 5 quarters. The position peaked at $1.35M in Q3 2018. 51 funds tracked by Wall St. Rank hold INFI as of Q3 2019.

First Eagle Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
First Eagle Investment Management sold 500,000 Infinity Pharmaceuticals, Inc. shares in Q3 2019, an estimated $900K.
First Eagle Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2018 and held it in 5 quarters.
First Eagle Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $1.35M in Q3 2018.
51 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2019.

Based on First Eagle Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.